About
From the very beginning, the principles of personal competence of all employees, flexibility in complying with requirements of sponsors and/or studies, and excellent quality of our endeavours guided the development of IMEREM until now.
We invest continuously in the qualification of all members of our company to enable efficient work in high quality. We are not primarily interested in maximizing our profit on the costs of poor or “normal” quality of our studies. Instead, all our activities are determined by a fighting spirit for the success of any clinical trial we are engaged in.
To be more exact: we are favoring planning in every respect (protocol, CRF, monitoring, CRF completion, validation, statistical analysis), like other CROs. However, all our members are aware and thoroughly trained that a p-value will be decisive at the very end of (almost) every trial. This attitude guides the awareness of what experts call the “assay sensitivity”, in other words, maximizing the internal quality of a trial in every activity within a clinical study. This includes hotlines for immediate problem solving within hours.
Eighteen years of clinical research are a challenge of permanent learning and an accumulation of extraordinary knowhow and stable relationships to investigators.
